Selected article for: "activity level and expression level"
Author: Zhenhua Zeng; Tong Sha; Yuan Zhang; Feng Wu; Hongbin Hu; Haijun Li; Jiafa Han; Wenhong Song; Qiaobing Huang; Zhongqing Chen
Title: Hypertension in patients hospitalized with COVID-19 in Wuhan, China: A single-center retrospective observational study
  • Document date: 2020_4_11
    • ID: lujxql3a_34
    Snippet: is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.04.06.20054825 doi: medRxiv preprint to that of ACE. ACE2 can hydrolyze angiotensin I (Ang I) to produce angiotensin (1-7) peptides, thereby generating vasodilation and lowering blood pressure. ACEI/ARB drugs may increase the protein concentration of ACE2 in rat plasma, mRNA level of ACE2, and even the activity of ACE2 in cardiac tissue 14 ......
    Document: is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.04.06.20054825 doi: medRxiv preprint to that of ACE. ACE2 can hydrolyze angiotensin I (Ang I) to produce angiotensin (1-7) peptides, thereby generating vasodilation and lowering blood pressure. ACEI/ARB drugs may increase the protein concentration of ACE2 in rat plasma, mRNA level of ACE2, and even the activity of ACE2 in cardiac tissue 14 . Thus, it is possible that those hypertensive patients who had been taking ACEI/ARB might have an increased level of mRNA and protein expression of ACE2 in the lungs, making them more vulnerable for SARS-COV-2 entry, as well as for development of severe COVID-19 pneumonia. These findings are worth investigating further.

    Search related documents:
    Co phrase search for related documents
    • ARB drug and SARS entry: 1
    • blood pressure and cardiac tissue: 1, 2, 3, 4, 5, 6
    • blood pressure and hypertensive patient: 1, 2, 3, 4, 5, 6
    • blood pressure and increase level: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • blood pressure and mRNA level: 1
    • blood pressure and protein concentration: 1, 2, 3, 4, 5
    • blood pressure and protein expression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • blood pressure and SARS entry: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • blood pressure and severe pneumonia: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • blood pressure and severe pneumonia development: 1
    • blood pressure lower and protein expression: 1
    • blood pressure lower and severe pneumonia: 1, 2
    • cardiac tissue and mRNA level: 1
    • cardiac tissue and protein expression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • cardiac tissue and SARS entry: 1, 2, 3, 4, 5, 6, 7
    • hypertensive patient and severe pneumonia: 1, 2, 3, 4, 5
    • increase level and protein expression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • increase level and SARS entry: 1, 2
    • increase level and severe pneumonia: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10